Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/19/2848957/0/en/Longeveron-Announces-1-for-10-Reverse-Stock-Split.html
https://www.fiercebiotech.com/biotech/cash-runways-running-out-year-nicox-and-longeveron-plan-layoffs-and-narrow-focus
https://www.globenewswire.com//news-release/2024/02/27/2836433/0/en/Longeveron-Reports-Year-End-2023-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/21/2833127/0/en/Longeveron-to-Report-Year-End-2023-Results-and-Provide-Corporate-Update-February-27-2024.html
https://www.globenewswire.com/news-release/2024/01/29/2818846/0/en/Longeveron-Receives-Notice-of-United-States-Patent-Allowance-for-the-Technology-Behind-its-Lead-Investigation-Product-Lomecel-B.html
https://www.globenewswire.com/news-release/2023/12/22/2800825/0/en/Longeveron-Announces-Closing-of-2-36-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2023/12/21/2800146/0/en/UPDATE-Longeveron-Announces-2-36-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2023/12/21/2799969/0/en/Longeveron-Announces-2-36-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2023/12/20/2799201/0/en/Longeveron-Announces-Additional-Positive-Clinical-Data-and-Imaging-Biomarker-Results-from-the-CLEAR-MIND-Phase-2a-Trial-of-Lomecel-B-in-the-Treatment-of-Mild-Alzheimer-s-Disease.html
https://www.globenewswire.com//news-release/2023/11/11/2778601/0/en/Long-term-Survival-Data-from-Longeveron-s-ELPIS-1-Trial-Presented-at-the-2023-Scientific-Sessions-of-the-American-Heart-Association.html